# MYMD PHARMACEUTICALS INC (MYMD)

> Institutional ownership reported to the SEC as of Q1 2024, from Form 13F filings. Source: https://holderbook.com/stocks/MYMD/

- Reporting holders: 1
- Reported value: $43
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [St. Johns Investment Management Company, LLC](https://holderbook.com/funds/1605522-st-johns-investment-management-company-llc/) | $43 | 18 | 0.0% | 7 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q1 2024 | 1 | $43 |
| Q4 2023 | 48 | $1.7M |
| Q3 2023 | 50 | $2.7M |
| Q2 2023 | 45 | $6.8M |
| Q1 2023 | 48 | $7.2M |
| Q4 2022 | 38 | $4.7M |
| Q3 2022 | 43 | $10.5M |
| Q2 2022 | 34 | $10.3M |
| Q1 2022 | 33 | $23.5M |
| Q4 2021 | 40 | $29.5M |
| Q3 2021 | 29 | $42.1M |
| Q2 2021 | 23 | $30.8M |